HRTX Q1 2020 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$25M-19.6% YoY

Gross Profit

$15M58.2% margin

Operating Income

-$53M-207.6% margin

Net Income

-$52M-203.1% margin

EPS (Diluted)

$-0.57

QoQ Revenue Growth

-27.6%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$36M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$479M

Total Liabilities

$113M

Stockholders' Equity

$365M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$32M	-19.6%
Gross Profit	$15M	$17M	-11.2%
Operating Income	-$53M	-$65M	+18.5%
Net Income	-$52M	-$63M	+18.1%

Revenue Segments

C I N V A N T I

$25M99%

S U S T O L

$200,0001%